Stem Cell Therapy Market Overview

Stem cell therapy involves harvesting and processing a patient's own stem cells, which are then populated on bio-absorbable polymer scaffold and surgical implants. It dramatically exceeds outcomes achieved with existing conventional treatment. Therefore, stem cell therapy now represents the biotechnology industry's dominant, incumbent technology. Over the recent year, the stem cell therapy is gaining a huge market prominence, mainly due to its efficacy proven in the treatments of many chronic diseases such as diabetes, hematopoietic disorders, and degenerative disorders, among others.

Resultantly, the global Stem Cell Therapy Market is rising pervasively, witnessing increasing uptake of this therapeutics. The market is exploding with a number of researches currently ongoing, and there have been several breakthrough outcomes as well. According to Market Research Future (MRFR), the global stem cell therapy market is booming and expected garner fabulous accruals by 2030. In its recent market analysis, MRFR also asserts that the market would register around 10.74% CAGR throughout the review period (2022–2030).

The market is predominantly driven by the growing prevalence of various chronic diseases such as cancer, diabetes, hematopoietic disorders (leukemia, thalassemia, and others), degenerative disorders (osteoarthritis, Alzheimer's disease, Parkinson's disease, chronic renal failure, congestive cardiac failure,) and others. Additionally, enormously rising demand for stem cell therapy to control the growth of the above-mentioned diseases and disorders boost the market growth. Substantial investments made in R&D initiatives by government and private companies influence the growth of the market.

Request Free Sample Copy at:

Stem Cell Therapy Market Regional Analysis

Based on region, the stem cell therapy market segmented into the Americas, Europe, Asia-Pacific and the Middle East and Africa. The Americas lead the market on account of factors such as growing healthcare expenditure and existence of heart diseases. After the Americas, Europe (Netherlands, France, Belgium and UK) grabs the second position. This can be attributed to factors such as the rising occurrence of osteoarthritis, cancer and stroke.

It is the Asia-Pacific which is the fastest growing region in this market and is likely to see further growth due to the increasing existence of smoking here. The Middle East & Africa (MEA) region holds a relatively smaller share of market due to lack of well-trained healthcare experts and low per capita income. However, both the increasing technology and oncology in the community and the hospital level are likely to positively influence the stem cell therapy market.

Key Players

The leading players profiled in the report include Thermo Fisher Scientific Inc, AlloSource (US), RTI Surgical Inc (US), NuVasive Inc (US), JCR Pharmaceuticals Co. Ltd (Japan), HolostemTerapieAvanzateS.r.l. (Italy), Pharmicell Co., Ltd (South Korea), Anterogen Co., Ltd (South Korea), MEDIPOST Co., Ltd (South Korea), and Orisis Therapeutics, Inc. (US).

Latest research in September, 2018 jointly led by University of Pennsylvania and Fourth Military Medicine University revealed that stem cells from baby teeth can be harvested which will have prospective dental uses to repair and regenerate tissues and regrow the adult teeth without the need for dentures or crowns.

Browse Detailed TOC with COVID-19 Impact Analysis at:

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), & Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street, 5Th Floor,

New York, New York 10013

United States of America

+1 628 258 0071